Measuring individual benefits of psychiatric treatment using longitudinal binary outcomes: Application to antipsychotic benefits in non-cannabis and cannabis users.

Journal of Biopharmaceutical Statistics
Xuan ZhangF J Diaz

Abstract

We present and evaluate a method for predicting individual treatment benefits based on random effects logistic regression models of binary outcomes that change over time. The method uses empirical Bayes predictors based on patients' characteristics and responses to treatment. It is applicable to both 1-dimentional and 2-dimentional personalized medicine models. Comparisons between predicted and true benefits for simulated new patients using correlations, relative biases and mean-squared errors were used to evaluate prediction performance. The predicted benefits had relatively small biases and relatively high correlations with the true benefits in the simulated new patients. The predictors also captured estimated overall population trends in the evolution of individual benefits. The proposed approach can be used to retrospectively evaluate patients' responses in a clinical trial, or to retrospectively or prospectively predict individual benefits of different treatments for new patients using patients' characteristics and previous responses. The method is used to examine changes in the disorganized dimension of antipsychotic-naïve patients from an antipsychotic randomized clinical trial. Retrospective prediction of individual ben...Continue Reading

References

Apr 1, 1994·Archives of General Psychiatry·D H LinszenM E Lenior
Jan 1, 1997·Schizophrenia Bulletin·D H LinszenM A Lenior
Apr 9, 1999·European Archives of Psychiatry and Clinical Neuroscience·D Caspari
Sep 4, 2003·International Journal of Methods in Psychiatric Research·Ian R WhiteTim Croudace
Jul 16, 2005·European Psychiatry : the Journal of the Association of European Psychiatrists·Anton GrechRobin M Murray
Mar 18, 2006·Biometrics·Li C Liu, Donald Hedeker
Jul 19, 2006·Statistics in Medicine·Francisco J DiazJose de Leon
Aug 2, 2006·The British Journal of Psychiatry : the Journal of Mental Science·L HidesR McD Young
Jun 17, 2008·Progress in Neuro-psychopharmacology & Biological Psychiatry·Sheila BottsJose de Leon
Nov 4, 2008·The British Journal of Psychiatry : the Journal of Mental Science·Stanley ZammitGlyn Lewis
Dec 17, 2009·The American Journal of Bioethics : AJOB·Franklin G Miller, Luana Colloca
May 19, 2010·The American Journal of Psychiatry·Daniel J FotiEvelyn J Bromet
Jul 30, 2010·Clinical Trials : Journal of the Society for Clinical Trials·Stephen J RubergYanping Wang
Mar 1, 2012·Journal of Clinical Psychopharmacology·Jose de Leon
Mar 16, 2012·Journal of Biopharmaceutical Statistics·Francisco J DiazJose de Leon
Mar 8, 2013·Current Pharmacogenomics and Personalized Medicine·Francisco J DiazJose de Leon
Mar 19, 2013·Therapeutic Drug Monitoring·Francisco J Diaz, Jose de Leon
Apr 26, 2014·Pharmacopsychiatry·F J DiazJ de Leon
Sep 3, 2014·Pharmaceutical Statistics·Samuel IddiGeorge Kalema
Dec 24, 2014·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Sagnik BhattacharyyaP K McGuire
Sep 30, 2015·Statistics in Medicine·Stephen Senn
Oct 30, 2015·Journal of Psychopharmacology·Robin P Wilson, Sagnik Bhattacharyya
Jun 18, 2016·Statistics in Medicine·Xiaolu Zhu, Annie Qu
Aug 3, 2016·International Journal of Methods in Psychiatric Research·Beatriz CoboFrancisca López-Torrecillas
May 27, 2017·Computational and Mathematical Methods in Medicine·Anne-Laure BoulesteixMathias Fuchs
Sep 28, 2017·Statistics in Medicine·Nichole Andrews, Hyunkeun Cho
Nov 10, 2017·Statistical Methods in Medical Research·Francisco J Diaz
Mar 7, 2018·Statistics in Medicine·Scott PowersRobert Tibshirani
Jan 21, 2019·Clinical Pharmacology and Therapeutics·Jennifer S GewandterRobert H Dworkin

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Software Mentioned

Stata
SAS

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here